Document Detail


Medication abortion.
MedLine Citation:
PMID:  19407520     Owner:  NLM     Status:  MEDLINE    
Abstract/OtherAbstract:
Medical methods for pregnancy termination in early gestation offer women an alternative to surgical evacuation and have the potential to improve access globally to safe abortion. Several drug regimens are used with varying efficacy including mifepristone plus misoprostol, misoprostol alone, and methotrexate plus misoprostol. Where available, a mifepristone plus misoprostol regimen is most frequently used and is highly effective for early abortion. We review these drug regimens along with clinical practice recommendations including patient counseling and selection, regimen administration location, expected side effects, and follow-up procedures. Overall, women who choose medical abortion report high levels of satisfaction.
Authors:
Deborah Bartz; Alisa Goldberg
Publication Detail:
Type:  Journal Article; Review    
Journal Detail:
Title:  Clinical obstetrics and gynecology     Volume:  52     ISSN:  1532-5520     ISO Abbreviation:  Clin Obstet Gynecol     Publication Date:  2009 Jun 
Date Detail:
Created Date:  2009-05-01     Completed Date:  2009-07-24     Revised Date:  2009-11-11    
Medline Journal Info:
Nlm Unique ID:  0070014     Medline TA:  Clin Obstet Gynecol     Country:  United States    
Other Details:
Languages:  eng     Pagination:  140-50     Citation Subset:  IM    
Affiliation:
Department of Obstetrics, Gynecology, and Reproductive Biology, Harvard Medical School, Brigham and Women's Hospital, Planned Parenthood League of Massachusetts, Boston, Massachusetts, USA. dbartz@partners.org
Export Citation:
APA/MLA Format     Download EndNote     Download BibTex
MeSH Terms
Descriptor/Qualifier:
Abortifacient Agents, Nonsteroidal / adverse effects,  pharmacology,  therapeutic use*
Abortion, Induced
Counseling
Dilatation and Curettage
Drug Approval / statistics & numerical data
Female
Humans
Mifepristone / pharmacology,  therapeutic use*
Misoprostol / pharmacology,  therapeutic use*
Patient Acceptance of Health Care
Patient Selection
Pregnancy
World Health
Chemical
Reg. No./Substance:
0/Abortifacient Agents, Nonsteroidal; 59122-46-2/Misoprostol; 84371-65-3/Mifepristone

From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine


Previous Document:  What physicians need to know about the legal status of abortion in the United States.
Next Document:  First trimester surgical abortion.